01 5Ajinomoto Health & Nutrition North America Inc.
01 1AMINO ACID MIXTURE 219 (MIX C)
02 1AMINO ACID MIXTURE BLEND D
03 1AMINO ACID MIXTURE BLEND F
04 1AMINO ACID MIXTURE BLEND PMCB - PEDIATRIC BLEND
05 1AMINO ACID MIXTURE CS-TB
01 5Japan
ALANINE; ARGININE; GLYCINE; HISTIDINE; ISOLEUCINE; LEUCINE; LYSINE HYDROCHLORIDE; METHIONINE; PROLINE; SERINE; THREONINE; TYROSINE; VALINE
NDC Package Code : 51495-178
Start Marketing Date : 2022-10-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (22.01kg/100kg 12.23kg/100kg 10.95kg/100kg 5.1kg/100kg 6.38kg/100kg 7.76kg/100kg 7.71kg/100kg 4.25kg/100kg 7.23kg/100kg 5.32kg/100kg 4.47kg/100kg .43kg/100kg 6.17kg/100kg)
Marketing Category : DRUG FOR FURTHER PROCESSING
ALANINE; ARGININE; GLYCINE; HISTIDINE; ISOLEUCINE; LEUCINE; LYSINE HYDROCHLORIDE; METHIONINE; PHENYLALANINE; PROLINE; SERINE; THREONINE; TRYPTOPHAN; TYROSINE; VALINE
NDC Package Code : 51495-203
Start Marketing Date : 2022-10-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (8.5kg/100kg 9.55kg/100kg 4.56kg/100kg 6.4kg/100kg 7.6kg/100kg 9.1kg/100kg 8.5kg/100kg 7.6kg/100kg 5.1kg/100kg 5.3kg/100kg 4.56kg/100kg 5.75kg/100kg 2.42kg/100kg 2.69kg/100kg 12.45kg/100kg)
Marketing Category : DRUG FOR FURTHER PROCESSING
ALANINE; ARGININE; ASPARTIC ACID; GLUTAMIC ACID; GLYCINE; HISTIDINE; ISOLEUCINE; LEUCINE; LYSINE ACETATE; METHIONINE; PHENYLALANINE; PROLINE; SERINE; THREONINE; TRYPTOPHAN; TYROSINE; VALINE
NDC Package Code : 51495-199
Start Marketing Date : 2022-10-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (14.01kg/100kg 9.49kg/100kg 2.8kg/100kg 4.84kg/100kg 6.72kg/100kg 5.77kg/100kg 4.84kg/100kg 6.72kg/100kg 10.75kg/100kg 4.84kg/100kg 6.72kg/100kg 5.77kg/100kg 3.82kg/100kg 4.84kg/100kg 1.61kg/100kg .252kg/100kg 6.2kg/100kg)
Marketing Category : DRUG FOR FURTHER PROCESSING
ALANINE; ARGININE; ASPARTIC ACID; CYSTEINE; GLUTAMIC ACID; GLYCINE; HISTIDINE; ISOLEUCINE; LEUCINE; LYSINE HYDROCHLORIDE; METHIONINE; ORNITHINE HYDROCHLORIDE; PHENYLALANINE; PROLINE; SERINE; TAURINE; THREONINE; TRYPTOPHAN; TYROSINE; VALINE
NDC Package Code : 51495-205
Start Marketing Date : 2022-10-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (7.8kg/100kg 8.2kg/100kg 5.85kg/100kg 1.85kg/100kg 9.75kg/100kg 3.92kg/100kg 3.72kg/100kg 6.5kg/100kg 9.75kg/100kg 12.05kg/100kg 2.35kg/100kg 3.1kg/100kg 4.12kg/100kg 2.94kg/100kg 3.92kg/100kg .59kg/100kg 3.62kg/100kg 1.97kg/100kg .76kg/100kg 7.4kg/100kg)
Marketing Category : DRUG FOR FURTHER PROCESSING
ALANINE; ARGININE; GLYCINE; HISTIDINE; ISOLEUCINE; LEUCINE; LYSINE HYDROCHLORIDE; METHIONINE; PHENYLALANINE; PROLINE; SERINE; THREONINE; TRYPTOPHAN; TYROSINE; VALINE
NDC Package Code : 51495-201
Start Marketing Date : 2022-10-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (20.41kg/100kg 11.34kg/100kg 10.15kg/100kg 4.73kg/100kg 5.91kg/100kg 7.2kg/100kg 7.15kg/100kg 3.94kg/100kg 5.52kg/100kg 6.7kg/100kg 4.93kg/100kg 4.14kg/100kg 1.77kg/100kg .39kg/100kg 5.72kg/100kg)
Marketing Category : DRUG FOR FURTHER PROCESSING
83
PharmaCompass offers a list of Amino Acids Mixture API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Amino Acids Mixture manufacturer or Amino Acids Mixture supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Amino Acids Mixture manufacturer or Amino Acids Mixture supplier.
PharmaCompass also assists you with knowing the Amino Acids Mixture API Price utilized in the formulation of products. Amino Acids Mixture API Price is not always fixed or binding as the Amino Acids Mixture Price is obtained through a variety of data sources. The Amino Acids Mixture Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A TRAVASOL 5.5% IN PLASTIC CONTAINER manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of TRAVASOL 5.5% IN PLASTIC CONTAINER, including repackagers and relabelers. The FDA regulates TRAVASOL 5.5% IN PLASTIC CONTAINER manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. TRAVASOL 5.5% IN PLASTIC CONTAINER API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of TRAVASOL 5.5% IN PLASTIC CONTAINER manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A TRAVASOL 5.5% IN PLASTIC CONTAINER supplier is an individual or a company that provides TRAVASOL 5.5% IN PLASTIC CONTAINER active pharmaceutical ingredient (API) or TRAVASOL 5.5% IN PLASTIC CONTAINER finished formulations upon request. The TRAVASOL 5.5% IN PLASTIC CONTAINER suppliers may include TRAVASOL 5.5% IN PLASTIC CONTAINER API manufacturers, exporters, distributors and traders.
click here to find a list of TRAVASOL 5.5% IN PLASTIC CONTAINER suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing TRAVASOL 5.5% IN PLASTIC CONTAINER as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for TRAVASOL 5.5% IN PLASTIC CONTAINER API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture TRAVASOL 5.5% IN PLASTIC CONTAINER as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain TRAVASOL 5.5% IN PLASTIC CONTAINER and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a TRAVASOL 5.5% IN PLASTIC CONTAINER NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of TRAVASOL 5.5% IN PLASTIC CONTAINER suppliers with NDC on PharmaCompass.
We have 1 companies offering TRAVASOL 5.5% IN PLASTIC CONTAINER
Get in contact with the supplier of your choice:
